La cadena de opciones muestra datos clave de las opciones de acciones de Branchout Food a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Branchout Food..

Branchout Food (NASDAQ:BOF) Bolsa, Cadena de Opciones

Branchout Food

Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are primarily located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.

Branchout Food inc

Kyoto Financial Group Inc

Barclays analyst Raimo Lenschow maintains MongoDB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) with a Overweight and raises the price target from $290 to $345.

News

Price Target

Analyst Ratings

Barclays Maintains Overweight on MongoDB, Raises Price Target to $345

Barclays analyst Gena Wang maintains Kodiak Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOD#NASDAQ">KOD</a>) with a Underweight and raises the price target from $3 to $4.

Barclays Maintains Underweight on Kodiak Sciences, Raises Price Target to $4

Trading Ideas

AREN

The Arena Group Shares Resume Trade Then Again Halt On Circuit Breaker, This Time To The Downside, Stock Now Up 242.1%

Barclays analyst Raimo Lenschow maintains Intuit (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) with a Overweight and raises the price target from $740 to $800.

INTU

Barclays Maintains Overweight on Intuit, Raises Price Target to $800

OS Therapies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/OSTX#AMEX">OSTX</a>) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.12) by 50 percent. This is a 52.63 percent increase over losses of $(0.38) per share from the same period last year.

Earnings

OSTX

OS Therapies Q3 EPS $(0.18) Misses $(0.12) Estimate

Barclays analyst Christine Cho maintains Enlight Renewable Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENLT#NASDAQ">ENLT</a>) with a Overweight and raises the price target from $20 to $21.

ENLT

Barclays Maintains Overweight on Enlight Renewable Energy, Raises Price Target to $21

Deep-pocketed investors have adopted a bearish approach towards Dell Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in DELL usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options activities for Dell Technologies. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 27% leaning bullish and 72% bearish. Among these notable options, 2 are puts, totaling $139,063, and 9 are calls, amounting to $1,052,409.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $100.0 to $138.0 for Dell Technologies during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
In terms of liquidity and interest, the mean open interest for Dell Technologies options trades today is 1136.6 with a total volume of 2,244.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Dell Technologies's big money trades within a strike price range of $100.0 to $138.0 over the last 30 days.
<h3>Dell Technologies Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731682122_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DELL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/22/24</td>
<td>$8.25</td>
<td>$7.9</td>
<td>$7.9</td>
<td>$126.00</td>
<td>$191.2K</td>
<td>409</td>
<td>1.8K</td>
</tr>
<tr>
<td>DELL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/22/24</td>
<td>$8.85</td>
<td>$8.0</td>
<td>$8.0</td>
<td>$126.00</td>
<td>$160.0K</td>
<td>409</td>
<td>1.8K</td>
</tr>
<tr>
<td>DELL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/22/24</td>
<td>$8.2</td>
<td>$7.95</td>
<td>$7.95</td>
<td>$126.00</td>
<td>$159.0K</td>
<td>409</td>
<td>1.8K</td>
</tr>
<tr>
<td>DELL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$34.9</td>
<td>$32.9</td>
<td>$34.9</td>
<td>$100.00</td>
<td>$139.6K</td>
<td>2.6K</td>
<td>5</td>
</tr>
<tr>
<td>DELL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/22/24</td>
<td>$8.3</td>
<td>$7.9</td>
<td>$7.9</td>
<td>$126.00</td>
<td>$124.8K</td>
<td>409</td>
<td>1.8K</td>
</tr>
</tbody>
</table>

<h3>About Dell Technologies</h3>
Dell Technologies is a broad information technology vendor, primarily supplying hardware to enterprises. It is focused on premium and commercial personal computers and enterprise on-premises data center hardware. It holds top-three market shares in its core markets of personal computers, peripheral displays, mainstream servers, and external storage. Dell has a robust ecosystem of component and assembly partners, and also relies heavily on channel partners to fulfill its sales.
Following our analysis of the options activities associated with Dell Technologies, we pivot to a closer look at the company's own performance.
<h3>Dell Technologies's Current Market Status</h3>
<ul>
<li>Trading volume stands at 387,143, with DELL's price down by -1.53%, positioned at $132.37.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 11 days.</li>
</ul>
<h3>What The Experts Say On Dell Technologies</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $154.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Morgan Stanley continues to hold a Overweight rating for Dell Technologies, targeting a price of $154. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Dell Technologies with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Markets

DELL

A Closer Look at Dell Technologies's Options Market Dynamics

Financial giants have made a conspicuous bullish move on Oklo. Our analysis of options history for Oklo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>) revealed 9 unusual trades.
Delving into the details, we found 66% of traders were bullish, while 11% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $871,550, and 3 were calls, valued at $264,260.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $18.0 to $27.0 for Oklo over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Oklo's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Oklo's significant trades, within a strike price range of $18.0 to $27.0, over the past month.
<h3>Oklo Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731682117_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>OKLO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$4.5</td>
<td>$4.0</td>
<td>$4.0</td>
<td>$21.00</td>
<td>$396.8K</td>
<td>3.4K</td>
<td>1.0K</td>
</tr>
<tr>
<td>OKLO</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$10.1</td>
<td>$9.1</td>
<td>$9.55</td>
<td>$26.00</td>
<td>$148.0K</td>
<td>371</td>
<td>250</td>
</tr>
<tr>
<td>OKLO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$11.4</td>
<td>$6.8</td>
<td>$8.6</td>
<td>$25.00</td>
<td>$129.0K</td>
<td>179</td>
<td>150</td>
</tr>
<tr>
<td>OKLO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/06/24</td>
<td>$3.9</td>
<td>$3.6</td>
<td>$3.83</td>
<td>$18.00</td>
<td>$116.7K</td>
<td>10</td>
<td>308</td>
</tr>
<tr>
<td>OKLO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/22/24</td>
<td>$1.9</td>
<td>$1.85</td>
<td>$1.9</td>
<td>$20.00</td>
<td>$95.0K</td>
<td>117</td>
<td>609</td>
</tr>
</tbody>
</table>

<h3>About Oklo</h3>
Oklo Inc is developing advanced fission power plants to provide clean, reliable, and affordable energy at scale. It is pursuing two complementary tracks to address this demand: providing reliable, commercial-scale energy to customers; and selling used nuclear fuel recycling services to the U.S. market. The Company plans to commercialize its liquid metal fast reactor technology with the Aurora powerhouse product line. The first commercial Aurora powerhouse is designed to produce up to 15 megawatts of electricity (MWe) on both recycled nuclear fuel and fresh fuel.
After a thorough review of the options trading surrounding Oklo, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is Oklo Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 1,060,583, with OKLO's price down by -12.6%, positioned at $20.87.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 90 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Oklo with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

OKLO

Market Whales and Their Recent Bets on OKLO Options

Barclays analyst Raimo Lenschow maintains Elastic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTC#NYSE">ESTC</a>) with a Overweight and raises the price target from $95 to $105.

ESTC

Barclays Maintains Overweight on Elastic, Raises Price Target to $105

Cantor Fitzgerald analyst Ross Osborn reiterates Elutia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELUT#NASDAQ">ELUT</a>) with a Overweight and maintains $10 price target.

Reiteration

ELUT

Cantor Fitzgerald Reiterates Overweight on Elutia, Maintains $10 Price Target

Vertically integrated Gold Flora Corporation (CBOE: GRAM) (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/GRAM#OTCQB">GRAM</a>) released its financial results Thursday for the third quarter of fiscal 2024.
&#8220;Amid the ongoing challenges facing the broader industry, we&#8217;ve made significant strides in positioning ourselves for long-term success," said Laurie Holcomb, CEO and chairman. "We have strengthened our balance sheet through a capital raise, continued scaling the highly successful Gramlin brand, and have further optimized our vertically integrated operations to support our growth initiatives.&#8221;
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40484603/gold-floras-q2-a-mixed-bag-for-cannabis-with-ebitda-down-2m-margins-up-to-57">Gold Flora&#8217;s Q2: A Mixed Bag For Cannabis With EBITDA Down $2M, Margins Up To 57%</a>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
<h3 class="wp-block-heading">Q3 2024 Financial Highlights</h3>
<ul>
<li>Total revenue amounted to $32.6 million, representing a 3% increase from the second quarter of 2024.</li>
<li>Gross profit was $13.5 million, resulting in a 41% gross margin, and up 86% sequentially.</li>
<li>Adjusted gross profit totaled $21.1 million, with a 65% adjusted gross margin (excluding non-recurring adjustments).</li>
<li>Net loss was $18.9 million, representing a 21% reduction from the prior quarter.</li>
<li>Adjusted EBITDA came in positive at $2.8 million, representing a 241% improvement from the second quarter of 2024.</li>
<li>Golf Flora had $10.2 million in cash and equivalents at the end of the third quarter.</li>
</ul>
<h3 class="wp-block-heading">Operational Highlights</h3>
<ul>
<li>First-party product revenue in retail stores reached over 30% of total sales.</li>
<li>Flower harvest volume increased by 20% from the first quarter of 2024, driven by improved cultivation methods.</li>
<li>Launch of Gramlin live rosin products and expansion of rosin production capacity at the Desert Hot Springs campus.</li>
<li>&nbsp;Secured a senior loan facility for up to $13.15 million.</li>
<li>The company's shares began trading on the OTCQB Venture Market under the ticker &#8220;GRAM.&#8221;</li>
</ul>
<h3 class="wp-block-heading">GRAM Price Action</h3>
Gold Flora's shares traded 9.09% lower at $0.04 per share after the market close on Thursday afternoon.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38212246/woman-owned-gold-floras-strategic-cannabis-blueprint-30-in-house-sales-boost-profit">Gold Flora&#8217;s Strategic Cannabis Blueprint: 30% In-House Sales Boost, Profits, EBITDA Rise</a></li>
</ul>

Cannabis

GRAM

California Cannabis Co. Gold Flora: 241% QoQ Growth In Adjusted EBITDA, Narrows Net Loss By 21%

VanEck CEO Jan van Eck has made waves with a bold forecast: <a href="https://www.benzinga.com/startups/24/10/41434521/tesla-quietly-transfers-765-million-in-bitcoin-putting-musks-cryptocurrency-strategy-under-intense-s">Bitcoin </a>could skyrocket to $300,000 within five to 10 years. This optimistic projection rests on Bitcoin's ability to capture a substantial share of the gold market – a market long valued as a hedge against inflation.&nbsp;
Don't Miss:
<ul>
<li>Over the last five years, the price of gold has increased by approximately 83% – Investors like Bill O&#8217;Reilly and Rudy Giuliani are using this platform to <a href="https://www.benzinga.com/money/american-hartford-gold">create customized gold IRAs to help shield their savings from inflation and economic turbulence. </a></li>
<li>1 in four Americans own a share of Bitcoin according to Nasdaq – <a href="https://www.benzinga.com/money/binance-100">this platform touts returns as high as 12.5% APY and is giving $100 in welcome rewards if you sign up today.</a></li>
</ul>
According to van Eck, the rise of traditional financial institutions (or "TradFi") investing in Bitcoin drives this trend, with many viewing it as a digital alternative to gold. Van Eck suggested that Bitcoin could eventually reach half of gold's current market capitalization, giving the cryptocurrency a total valuation close to $7 trillion.&nbsp;
Recent data from CoinGecko aligns with this bullish outlook. Bitcoin recently set a record above $89,000, although it settled back to around $90,000 shortly after. Individual investors are jumping into Bitcoin ETFs, a trend that JPMorgan analysts expect to continue through 2025. These ETFs are increasingly seen as a sign that retail and institutional investors trust Bitcoin as a potential "digital gold."
Trending: This well known prop trading firm is offering 100% of your first $25,000 profit per account and 90% after that. <a href="https://www.benzinga.com/money/apex-trader-funding">Here's how to get a special 50% OFF CODE that lets you start out with monthly investments as low as $147 today.</a>
Michael Saylor, CEO of MicroStrategy and a known Bitcoin advocate, pointed out that in the future, bitcoin would be more valuable than gold. "Bitcoin is certainly at least digital gold, it's going to eat gold," Saylor said. "It's got all of the great attributes of gold and it's got none of the defects of gold."
However, Bitcoin's journey toward mainstream acceptance hasn't been without its skeptics. Critics caution that Bitcoin's notorious volatility might limit its role as a stable store of value. Regulatory uncertainty and high energy consumption also cast a shadow over its future.&nbsp;
Yet van Eck remains confident. Calling his prediction of $300,000 per Bitcoin a "reasonable base assumption," he emphasized his belief that the digital asset is increasingly embraced as a long-term store of value.&nbsp;
See Also: If you invested $100 in DOGE when Elon Musk first tweeted about it in 2019,<a href="https://www.benzinga.com/money/etoro-doge"> here&#8217;s how much you&#8217;d have today</a>.
<a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40937953/larry-fink-defies-blackrocks-largest-shareholder-to-make-a-bold-bet-on-bitcoin-heres-how-h">BlackRock CEO Larry Fink</a> echoed similar sentiments, describing Bitcoin as "an asset class by itself" and highlighting its potential value if regulatory clarity improves. "There's more to Bitcoin than meets the eye," Fink said, adding that its uniqueness could enhance its future relevance in finance.
The increasing popularity of Bitcoin ETFs supports van Eck's forecast. According to Investopedia,<a href="https://www.benzinga.com/24/11/41869353/massive-day-for-blackrocks-bitcoin-etf-as-trading-volume-reaches-unseen-levels-with-4-1-billion-traded"> BlackRock's Bitcoin ETF, IBIT,</a> has been outperforming its iShares Gold ETF in trading volume and value growth.
October saw some of the highest single-day inflows for Bitcoin ETFs, underscoring growing investor interest. BlackRock's IBIT ETF has shown steady gains, with its recent performance of $1.12 billion inflows, suggesting that demand for Bitcoin is not slowing down anytime soon.
Read Next:
<ul>
<li>Dogecoin millionaires are increasing –<a href="https://www.benzinga.com/money/dogecoin-millionaires"> investors with $1M+ in DOGE revealed!</a></li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

VanEck CEO Boldly Predicts Bitcoin At $300K Per Coin, Reaching Half Of Gold's Market Cap In The Face Of Growing Demand

Barclays analyst Raimo Lenschow maintains Couchbase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BASE#NASDAQ">BASE</a>) with a Overweight and raises the price target from $19 to $23.

BASE

Barclays Maintains Overweight on Couchbase, Raises Price Target to $23

The Arena Group Shares Halted On Circuit Breaker To the Upside, Stock Now Up 259.6%

<a href="https://apnews.com/article/general-motors-layoffs-cost-cutting-5e2cc6f8a3210ea364d670a1902a7c65#:~:text=DETROIT%20(AP)%20%E2%80%94%20General%20Motors,statement%20but%20gave%20few%20details.">https://apnews.com/article/general-motors-layoffs-cost-cutting-5e2cc6f8a3210ea364d670a1902a7c65#:~:text=DETROIT%20(AP)%20%E2%80%94%20General%20Motors,statement%20but%20gave%20few%20details.</a>
DETROIT (AP) — General Motors is laying off about 1,000 workers worldwide, shedding costs as it tries to compete in a crowded global automobile market.
The workers, mostly white collar, were notified about the decisions early Friday. The company confirmed the layoffs in a statement but gave few details.
"We need to optimize for speed and excellence," the statement said. "This includes operating with efficiency, ensuring we have the right team structure and focusing on our top priorities."
GM and other automakers have been navigating an uncertain transition to electric vehicles both in the U.S. and worldwide, trying to figure out where to invest capital and how fast the switch will happen.
The company has had to develop and update gas-powered models while investing in EV battery and assembly plants as well as minerals and other parts for the next generation of electric vehicles.
Through September, U.S. new EV sales are up 7.2% to about 936,000, according to <a href="http://motorintelligence.com/">Motorintelligence.com</a>. That's slower growth than the 47% increase in 2023. But EV sales this year are likely to surpass last year's record of 1.19 million, and the EV share of new vehicle sales this year is 7.9%, up from 7.6% last year.

Management

'General Motors Lays Off About 1,000 Workers, Cutting Costs To Compete In A Crowded Automobile Market' - AP

Cantor Fitzgerald analyst Li Watsek reiterates Ascendis Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASND#NASDAQ">ASND</a>) with a Overweight and maintains $170 price target.

ASND

Cantor Fitzgerald Reiterates Overweight on Ascendis Pharma, Maintains $170 Price Target

<a href="https://www.cnbc.com/2024/11/15/elon-musks-xai-raising-up-to-6-billion-to-purchase-100000-nvidia-chips-for-memphis-data-center.html" title="https://www.cnbc.com/2024/11/15/elon-musks-xai-raising-up-to-6-billion-to-purchase-100000-nvidia-chips-for-memphis-data-center.html">https://www.cnbc.com/2024/11/15/elon-musks-xai-raising-up-to-6-billion-to-purchase-100000-nvidia-chips-for-memphis-data-center.html</a>

DXYZ

NVDA

Musk's xAI Seeking Up To $6B In New Funding, Projected Post-Raise Valuation Over $50B; Middle Eastern Sovereign Funds Expected As Key Investors, Funds To Support Purchase Of 100,000 H100s For Memphis Cloud Cluster

Xcel Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELB#NASDAQ">XELB</a>) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.11) by 254.55 percent. This is a 160 percent decrease over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $1.90 million which beat the analyst consensus estimate of $1.60 million by 18.75 percent. This is a 27.95 percent decrease over sales of $2.64 million the same period last year.

XELB

Xcel Brands Q3 EPS $(0.39) Misses $(0.11) Estimate, Sales $1.90M Beat $1.60M Estimate

Cantor Fitzgerald analyst C J Muse reiterates Applied Mat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) with a Overweight and maintains $250 price target.

AMAT

Cantor Fitzgerald Reiterates Overweight on Applied Mat, Maintains $250 Price Target

Cantor Fitzgerald analyst Kristen Kluska reiterates Codexis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDXS#NASDAQ">CDXS</a>) with a Overweight and maintains $11 price target.

CDXS

Cantor Fitzgerald Reiterates Overweight on Codexis, Maintains $11 Price Target

PEGY, CGEM and IFBD among mid-day movers

NKTR, IMNM and  MAIA are among premarket gainers

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Branchout Food (NASDAQ:<a href="https://investorplace.com/stock-quotes/bof-stock-quote/">BOF</a>) just reported results for the first quarter of 2024.<ul><li>Branchout Food reported earnings per share of -26 cents.</li><li>The company reported revenue of $1.47 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/bof-stock-earnings-branchout-food-for-q1-of-2024/">BOF Stock Earnings: Branchout Food Reported Results for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

BOF Stock Earnings: Branchout Food Reported Results for Q1 2024

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth checking out on Thursday as we dig into all of the news moving shares this morning!



Moving stocks are public offering updates, new investments an earnings report and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Assure (NASDAQ:<a href="https://investorplace.com/stock-quotes/ionm-stock-quote/">IONM</a>) stock is rocketing more than 128% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318417463&amp;type=PDF&amp;symbol=IONM&amp;cdn=8d8708e472ad2a1117d6e2e1ea234033&amp;companyName=Assure+Holdings+Corp.&amp;formType=RW&amp;formDescription=Registration+Withdrawal+Request&amp;dateFiled=2024-06-26">withdrawing a proposed public offering</a>.</li>



<li>Vigil Neuroscience (NASDAQ:<a href="https://investorplace.com/stock-quotes/vigl-stock-quote/">VIGL</a>) shares are soaring over 40% on a <a href="https://www.globenewswire.com/news-release/2024/06/27/2904902/0/en/Vigil-Neuroscience-Announces-40-Million-Strategic-Investment-from-Sanofi.html">$40 million investment</a>.</li>



<li>CASI Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/casi-stock-quote/">CASI</a>) stock is surging more than 31% on a <a href="https://www.prnewswire.com/news-releases/casi-pharmaceuticals-announces-15-million-private-placement-financing-by-venrock-healthcare-capital-partners-foresite-capital-panacea-venture-and-dr-wei-wu-he-302183230.html">$15 million private placement</a>.</li>



<li>Entero Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/ento-stock-quote/">ENTO</a>) shares are gaining over 26% on a <a href="https://www.nasdaq.com/press-release/entero-therapeutics-announces-peer-reviewed-publication-unveiling-novel-algorithm">peer-reviewed publication</a>.</li>



<li>Faraday Future (NASDAQ:<a href="https://investorplace.com/stock-quotes/ffie-stock-quote/">FFIE</a>) stock is increasing more than 24% as it <a href="https://investorplace.com/2024/06/faraday-future-ffie-stock-soars-80-following-rivian-volkswagen-deal/">continues a recent rally</a>.</li>



<li>Incannex Healthcare (NASDAQ:<a href="https://investorplace.com/stock-quotes/ixhl-stock-quote/">IXHL</a>) shares are jumping over 23% despite a lack of news this morning.</li>



<li>Geovax Labs (NASDAQ:<a href="https://investorplace.com/stock-quotes/govx-stock-quote/">GOVX</a>) stock is climbing more than 21% without any clear news this morning.</li>



<li>Fresh Vine Wine (NYSEMKT:<a href="https://investorplace.com/stock-quotes/vine-stock-quote/">VINE</a>) shares are heading close to 17% higher with heavy pre-market trading.</li>



<li>Phunware (NASDAQ:<a href="https://investorplace.com/stock-quotes/phun-stock-quote/">PHUN</a>) stock is getting an over 15% boost without any obvious news to report.</li>



<li>Hyzon Motors (NASDAQ:<a href="https://investorplace.com/stock-quotes/hyzn-stock-quote/">HYZN</a>) shares are up nearly 15% with strong trading this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Branchout Food (NASDAQ:<a href="https://investorplace.com/stock-quotes/bof-stock-quote/">BOF</a>) stock is plummeting more than 37% after <a href="https://www.nasdaq.com/press-release/branchout-food-prices-14-million-follow-public-offering-2024-06-26">pricing a follow-on offering</a>.</li>



<li>Tonix Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/tnxp-stock-quote/">TNXP</a>) shares are diving over 28% on a <a href="https://www.stocktitan.net/news/TNXP/tonix-pharmaceuticals-announces-proposed-public-d6yhuinwfxm9.html">proposed public offering</a>.</li>



<li>Bluejay Diagnostics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bjdx-stock-quote/">BJDX</a>) stock is tumbling more than 21% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318418078&amp;type=PDF&amp;symbol=BJDX&amp;cdn=14a15ef82de2ebc313ddbbf7cad3f31c&amp;companyName=Bluejay+Diagnostics+Inc.&amp;formType=EFFECT&amp;formDescription=Notice+of+Effectiveness&amp;dateFiled=2024-06-26">effecting a public offering</a>.</li>



<li>Immutep (NASDAQ:<a href="https://investorplace.com/stock-quotes/immp-stock-quote/">IMMP</a>) shares are taking an over 17% beating without any apparent news today.</li>



<li>VSee Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/vsee-stock-quote/">VSEE</a>) stock is slipping more than 17% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318417950&amp;type=PDF&amp;symbol=VSEE&amp;cdn=a8750adb0a7c7d12db86db6bfac8e49b&amp;companyName=VSee+Health+Inc.&amp;formType=4&amp;formDescription=Statement+of+changes+in+beneficial+ownership+of+securities&amp;dateFiled=2024-06-26">alongside recent insider trading</a>.</li>



<li>Swvl (NASDAQ:<a href="https://investorplace.com/stock-quotes/swvl-stock-quote/">SWVL</a>) shares are dropping over 16% on Thursday morning.</li>



<li>Levi Strauss (NYSE:<a href="https://investorplace.com/stock-quotes/levi-stock-quote/">LEVI</a>) stock is decreasing more than 16% with its <a href="https://www.cnbc.com/2024/06/26/levi-levi-earnings-q2-2024.html">Q2 earnings report</a>.</li>



<li>International Paper (NYSE:<a href="https://investorplace.com/stock-quotes/ip-stock-quote/">IP</a>) shares are falling over 15% today.</li>



<li>Recursion Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/rxrx-stock-quote/">RXRX</a>) stock is slipping more than 14% after <a href="https://www.stocktitan.net/news/RXRX/recursion-announces-pricing-of-200-million-public-offering-of-class-49il22g17787.html">pricing a public offering</a>.</li>



<li>KraneShares California Carbon Allowance Strategy ETF (NYSEARCA:<a href="https://investorplace.com/stock-quotes/kcca-stock-quote/">KCCA</a>) shares close out our pre-market stock movers down over 13%. </li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-june-27th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Branchout Food&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/bof-stock-quote/">BOF</a>) stock is falling on Thursday after the dehydrated fruit and vegetable snacks company <a href="https://www.nasdaq.com/press-release/branchout-food-prices-14-million-follow-public-offering-2024-06-26">priced a public offering</a> for its shares.



This has Branchout Food offering investors 1.75 million shares of BOF stock for 80 cents each. That has the company expecting to raise gross proceeds of $1.4 million from the offering.



Branchout Food already has plans for the money gained from this public offering. The company will use it for working capital and general corporate purposes. That includes operating expenses and capital expenditures.



There&rsquo;s also a 45-day option for underwriters to acquire another 262,500 shares at the offering price. Alexander Capital L.P. is the sole bookrunner for the BOF stock offering.



<h2>What This Means for BOF Stock</h2>



With this comes an increase in the total number of outstanding BOF shares. That will dilute the stakes of current investors in the company. This is one of the reasons why BOF stock is falling today.



On top of that, the 80 cents price for BOF shares is a significant discount. For comparison, the stock closed out Wednesday at $1.31 per share. That&rsquo;s another reason for shares losing value today.



BOF stock is down 38.9% as of Thursday morning.



Investors will want to keep reading for more of the most recent stock market stories!



We have all of the hottest stock market news available on Thursday! A few examples include what&rsquo;s going on with shares of Vigil Neuroscience&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/vigl-stock-quote/">VIGL</a>) and Assure&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/ionm-stock-quote/">IONM</a>) stock, as well as the biggest pre-market movers this morning. All of this is available at the links below!



<h2>More Thursday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/06/why-is-vigil-neuroscience-vigl-stock-up-32-today/">Why Is Vigil Neuroscience (VIGL) Stock Up 32% Today?</a></li>



<li><a href="https://investorplace.com/2024/06/why-is-assure-ionm-stock-up-191-today/">Why Is Assure (IONM) Stock Up 191% Today?</a></li>



<li><a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-june-27th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Thursday</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/why-is-branchout-food-bof-stock-down-39-today/">Why Is Branchout Food (BOF) Stock Down 39% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Branchout Food (BOF) Stock Down 39% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Tonix Pharmaceuticals&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/tnxp-stock-quote/">TNXP</a>) stock is falling on Thursday after the biopharmaceutical company announced a <a href="https://finance.yahoo.com/news/tonix-pharmaceuticals-announces-proposed-public-204000580.html">proposed public offering</a> for its shares.



Tonix Pharmaceuticals doesn&rsquo;t have the finer details of this offering ready just yet. That means we don&rsquo;t know how many shares it includes, what they will be priced at or how much it expects in gross proceeds.



What we do know is what the company plans to do with the money it will raise. Tonix Pharmaceuticals says funds from this proposed offering will go toward working capital and general corporate purposes.



To be more specific, Tonix Pharmaceuticals wants to use the money to prepare a new drug application for its Tonmya product candidate to treat fibromyalgia. It could also use the funds to pay down its debts.



<h2>TNXP Stock Nasdaq Compliance</h2>



Investors will note that Tonix Pharmaceuticals announced this proposed public offering <a href="https://finance.yahoo.com/news/tonix-pharmaceuticals-regains-compliance-nasdaq-191300480.html">right after regaining compliance</a> with the Nasdaq Exchange&rsquo;s listing requirements.



Tonix Pharmaceuticals did this by getting its share price above the $1.00 minimum bid for 10 consecutive trading days. After announcing its public offering, the shares are trading at about 76 cents each this morning.



TNXP stock is down 32.5% as of Thursday morning.



Investors will want to keep reading for more of the latest stock market stories today!



We are offering all of the most recent stock market news for Thursday! That includes all of the latest news concerning shares of Branchout Food&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/bof-stock-quote/">BOF</a>) stock, Ur-Energy&nbsp;(NYSEMKT:<a href="https://investorplace.com/stock-quotes/urg-stock-quote/">URG</a>)&nbsp;stock and Vigil Neuroscience&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/vigl-stock-quote/">VIGL</a>) stock this morning. You can catch up on all of this news by checking out the links below!



<h2>More Stock Market News for Thursday</h2>



<ul><li><a href="https://investorplace.com/2024/06/why-is-branchout-food-bof-stock-down-39-today/">Why Is Branchout Food (BOF) Stock Down 39% Today?</a></li>



<li><a href="https://investorplace.com/2024/06/trade-of-the-day-ur-energy-urg-stock-is-a-high-risk-bet-on-ai-demand/">Trade of the Day: Ur-Energy (URG) Stock Is a High-Risk Bet on AI Demand</a></li>



<li><a href="https://investorplace.com/2024/06/why-is-vigil-neuroscience-vigl-stock-up-32-today/">Why Is Vigil Neuroscience (VIGL) Stock Up 32% Today?</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/why-is-tonix-pharmaceuticals-tnxp-stock-down-33-today/">Why Is Tonix Pharmaceuticals (TNXP) Stock Down 33% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Tonix Pharmaceuticals (TNXP) Stock Down 33% Today?

BranchOut Food announces $3.925M CEO-led investment

The latest update is out from BranchOut Food Inc. (BOF). BranchOut Food Inc. has engaged in strategic financing activities by selling securities to...

BranchOut Food Inc. Bolsters Finance with Strategic Deals and Offerings

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Branchout Food (NASDAQ:<a href="https://investorplace.com/stock-quotes/bof-stock-quote/">BOF</a>) just reported results for the second quarter of 2024.<ul><li>Branchout Food reported earnings per share of -22 cents.</li><li>The company reported revenue of $1.36 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/bof-stock-earnings-branchout-food-for-q2-of-2024/">BOF Stock Earnings: Branchout Food Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

BOF Stock Earnings: Branchout Food Reported Results for Q2 2024

BranchOut Food reports H1 results

AGEN

AIRE

ATOM

AWIN

BACK

BJDX

CASI

CGEM

ENTO

FFIE

GOVX

HYZN

ICLK

IFBD

IMMP

IONM

IXHL

KCCA

LEVI

NIVF

NUZE

NWGL

PEGY

PHUN

RXRX

SAIA

SNAP

SWVL

TNXP

VIGL

VINE

VSEE

ZVSA

Press Releases

General

U.S. Army Selects BranchOut Food Products for Field Test with Aim of Revolutionizing MREs

BranchOut Food Enters the $300 Billion Industrial Food Ingredients Market

BranchOut Food Ships First Production of New, Innovative Products to Nation's Largest Retailer, Initiating Second of Three Existing Contracts Totaling $8M

Financing

BranchOut Food Prices $1.4 Million Follow-On Public Offering

Contracts

Restaurants

BranchOut Food Announces Nation's Largest Retailer Increases Third Contract to Approximately $1M Annually, Triples Original Commitment

BranchOut Food Announces Closing of $1.4 Million Follow-On Public Offering

BranchOut Food Inc. Announces $3.925M CEO-led Investment Including an Insider PIPE and Convertible note

BranchOut Food Delivers Shareholder Update: 2024 Revenue Surges 640% in First Half, Poised for Continued Growth and Debt Elimination by Q4 2025

A New Standard in Drug Testing: Intelligent Bio (NASDAQ: INBS) Delivering Cost-Efficiency, Rapid Results, and Employee Dignity more stocks inside…

BranchOut Food Shareholder Update: Projects $15M Run Rate and Positive Cash Flow for Q1 2025 Amid Surge in New Orders as Peru Factory Opens

Comments

Branchout Food

Branchout Food (BOF) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL